JP2024528418A5 - - Google Patents
Info
- Publication number
- JP2024528418A5 JP2024528418A5 JP2023577590A JP2023577590A JP2024528418A5 JP 2024528418 A5 JP2024528418 A5 JP 2024528418A5 JP 2023577590 A JP2023577590 A JP 2023577590A JP 2023577590 A JP2023577590 A JP 2023577590A JP 2024528418 A5 JP2024528418 A5 JP 2024528418A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- vaccine composition
- composition according
- antigen
- influenza vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163212523P | 2021-06-18 | 2021-06-18 | |
| US63/212,523 | 2021-06-18 | ||
| EP21315198.8 | 2021-10-13 | ||
| EP21315198 | 2021-10-13 | ||
| US202163276243P | 2021-11-05 | 2021-11-05 | |
| PCT/US2021/058250 WO2022099003A1 (en) | 2020-11-06 | 2021-11-05 | Lipid nanoparticles for delivering mrna vaccines |
| USPCT/US2021/058250 | 2021-11-05 | ||
| US63/276,243 | 2021-11-05 | ||
| PCT/IB2022/055655 WO2022264109A1 (en) | 2021-06-18 | 2022-06-17 | Multivalent influenza vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528418A JP2024528418A (ja) | 2024-07-30 |
| JP2024528418A5 true JP2024528418A5 (enExample) | 2025-06-24 |
Family
ID=82258335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577590A Pending JP2024528418A (ja) | 2021-06-18 | 2022-06-17 | 多価インフルエンザワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230043128A1 (enExample) |
| EP (1) | EP4355308A1 (enExample) |
| JP (1) | JP2024528418A (enExample) |
| KR (1) | KR20240022610A (enExample) |
| AU (1) | AU2022294274A1 (enExample) |
| CA (1) | CA3224175A1 (enExample) |
| IL (1) | IL309408A (enExample) |
| MX (1) | MX2023015464A (enExample) |
| WO (1) | WO2022264109A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022099003A1 (en) | 2020-11-06 | 2022-05-12 | Sanofi | Lipid nanoparticles for delivering mrna vaccines |
| BR112023020027A2 (pt) * | 2021-04-15 | 2023-11-14 | Translate Bio Inc | Lipídeos catiônicos baseados em tampão "good" |
| EP4642481A2 (en) | 2022-12-29 | 2025-11-05 | Popvax Private Limited | Multitarget vaccines and therapeutics |
| EP4665390A1 (en) * | 2023-02-13 | 2025-12-24 | Pfizer Inc. | Immunogenic composition against influenza |
| JP2026518411A (ja) * | 2023-04-27 | 2026-06-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | インフルエンザウイルスワクチン |
| EP4701657A1 (en) * | 2023-04-27 | 2026-03-04 | GlaxoSmithKline Biologicals S.A. | Influenza virus vaccines |
| WO2025003760A1 (en) * | 2023-06-28 | 2025-01-02 | Sanofi | Sterol analogs in lipid nanoparticle formulations |
| CN122422511A (zh) * | 2023-10-31 | 2026-07-17 | 仁景(苏州)生物科技有限公司 | 一种多价流感mRNA疫苗 |
| CN117205309B (zh) * | 2023-11-07 | 2024-02-02 | 今发制药(南京)有限公司 | 一种流感免疫原组合物和制备方法及其用途 |
| US20250332245A1 (en) * | 2023-11-15 | 2025-10-30 | Pfizer Inc. | Immunogenic compositions against influenza |
| CN117511969B (zh) * | 2024-01-04 | 2024-03-19 | 华南农业大学 | 一种mRNA、制备方法、用途和疫苗 |
| WO2025196065A1 (en) * | 2024-03-20 | 2025-09-25 | Sanofi | Novel homocysteine based lipids and their use for delivery of nucleic acids |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| PT1751289E (pt) | 2004-05-18 | 2009-03-31 | Alphavax Inc | Vectores de alfavirais derivados da tc-83, partículas e métodos |
| EP2451475A2 (en) | 2009-07-06 | 2012-05-16 | Novartis AG | Self replicating rna molecules and uses thereof |
| SI2506857T1 (en) | 2009-12-01 | 2018-08-31 | Translate Bio, Inc. | Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases |
| US8853377B2 (en) | 2010-11-30 | 2014-10-07 | Shire Human Genetic Therapies, Inc. | mRNA for use in treatment of human genetic diseases |
| KR20220025112A (ko) | 2011-06-08 | 2022-03-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | Mrna 전달을 위한 지질 나노입자 조성물 및 방법 |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| EA201492055A1 (ru) | 2012-06-08 | 2015-11-30 | Шир Хьюман Дженетик Терапис, Инк. | ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ |
| EA201591283A1 (ru) | 2013-03-14 | 2016-02-29 | Шир Хьюман Дженетик Терапис, Инк. | Количественная оценка эффективности кэп матричной рнк |
| ES2967701T3 (es) | 2013-03-15 | 2024-05-03 | Translate Bio Inc | Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas |
| SG10201801428RA (en) | 2013-08-21 | 2018-03-28 | Curevac Ag | Method for increasing expression of rna-encoded proteins |
| WO2015062738A1 (en) | 2013-11-01 | 2015-05-07 | Curevac Gmbh | Modified rna with decreased immunostimulatory properties |
| CA2927254C (en) | 2013-12-30 | 2023-10-24 | Curevac Ag | Artificial nucleic acid molecules |
| AU2014375402B2 (en) | 2013-12-30 | 2020-10-01 | CureVac SE | Artificial nucleic acid molecules |
| WO2016004318A1 (en) | 2014-07-02 | 2016-01-07 | Shire Human Genetic Therapies, Inc. | Encapsulation of messenger rna |
| EP4023755B1 (en) | 2014-12-12 | 2023-04-26 | CureVac SE | Artificial nucleic acid molecules for improved protein expression |
| WO2016174271A1 (en) | 2015-04-30 | 2016-11-03 | Curevac Ag | Immobilized poly(n)polymerase |
| RS64331B1 (sr) | 2015-06-19 | 2023-08-31 | Massachusetts Inst Technology | Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta |
| MA46023A (fr) * | 2015-10-22 | 2019-07-03 | Modernatx Inc | Vaccin contre le virus de la grippe à large spectre |
| WO2017162265A1 (en) | 2016-03-21 | 2017-09-28 | Biontech Rna Pharmaceuticals Gmbh | Trans-replicating rna |
| KR20190093816A (ko) * | 2016-10-26 | 2019-08-26 | 큐어백 아게 | 지질 나노입자 mRNA 백신 |
| US20180153822A1 (en) | 2016-11-10 | 2018-06-07 | Translate Bio, Inc. | Process of Preparing mRNA-Loaded Lipid Nanoparticles |
| CN116549671A (zh) | 2016-11-10 | 2023-08-08 | 川斯勒佰尔公司 | 用于递送mrna的改进的基于ice的脂质纳米颗粒制剂 |
| MA46766A (fr) * | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| EP3849617A1 (en) * | 2018-09-14 | 2021-07-21 | Translate Bio, Inc. | Composition and methods for treatment of methylmalonic acidemia |
| WO2021080999A1 (en) | 2019-10-21 | 2021-04-29 | Sanofi Pasteur, Inc. | Systems and methods for predicting biological responses |
| DK4049290T3 (da) | 2019-10-21 | 2025-12-08 | Sanofi Pasteur Inc | Systemer og fremgangsmåder til design af vacciner |
| CN116406299A (zh) * | 2020-11-06 | 2023-07-07 | 赛诺菲 | 用于递送mRNA疫苗的脂质纳米颗粒 |
-
2022
- 2022-06-17 AU AU2022294274A patent/AU2022294274A1/en not_active Abandoned
- 2022-06-17 IL IL309408A patent/IL309408A/en unknown
- 2022-06-17 CA CA3224175A patent/CA3224175A1/en active Pending
- 2022-06-17 JP JP2023577590A patent/JP2024528418A/ja active Pending
- 2022-06-17 US US17/843,445 patent/US20230043128A1/en active Pending
- 2022-06-17 MX MX2023015464A patent/MX2023015464A/es unknown
- 2022-06-17 WO PCT/IB2022/055655 patent/WO2022264109A1/en not_active Ceased
- 2022-06-17 KR KR1020247001675A patent/KR20240022610A/ko active Pending
- 2022-06-17 EP EP22734371.2A patent/EP4355308A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023550600A5 (enExample) | ||
| JP7817257B2 (ja) | ｍＲＮＡワクチンを送達するための脂質ナノ粒子 | |
| TW202233232A (zh) | 遞送mRNA疫苗的脂質奈米顆粒 | |
| ES2731899T3 (es) | Composición de vacuna nasal contra la gripe | |
| RU2019126746A (ru) | Способы лечения гриппа | |
| JP5764621B2 (ja) | インフルエンザを阻害する組成物および方法 | |
| IL321503A (en) | Recombinant virus, composition comprising the same, and uses thereof | |
| JP2024528418A (ja) | 多価インフルエンザワクチン | |
| CN106573045B (zh) | 流感疫苗经鼻接种系统 | |
| AU2021202331A1 (en) | Vaccination of immunocompromised subjects | |
| KR20240002207A (ko) | 코로나바이러스 백신 | |
| US12121503B2 (en) | Antiviral treatments | |
| Hendy et al. | Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine | |
| CN121419787A (zh) | 多价流感mRNA疫苗 | |
| Meunier et al. | Influenza pathogenesis: lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza | |
| JP2024540290A5 (enExample) | ||
| RU2024101100A (ru) | Поливалентные вакцины против гриппа | |
| HK1212250A1 (en) | Antiviral compounds, unit dosage form comprising said compounds and use thereof | |
| RU2023114690A (ru) | ЛИПИДНЫЕ НАНОЧАСТИЦЫ ДЛЯ ДОСТАВКИ mRNA-ВАКЦИНA | |
| EP2970386A2 (en) | Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith | |
| AU2016262644B2 (en) | Intravenous antiviral treatments | |
| CN107286044B (zh) | 一种能够抑制流感病毒pb2蛋白与rna帽结合的化合物 | |
| JP2025536956A (ja) | 目的遺伝子ｒｎａ製剤 | |
| WO2022210764A1 (ja) | 経鼻投与インフルエンザワクチン | |
| TH1901004849A (th) | องค์ประกอบสำหรับการรักษาไข้หวัดใหญ่ |